Kovack Advisors, Inc. Gilead Sciences, Inc. Transaction History

Kovack Advisors, Inc.

  • $919 Million
  • Q3 2024

A detailed history of Kovack Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kovack Advisors, Inc. holds 9,113 shares of GILD stock, worth $821,901. This represents 0.08% of its overall portfolio holdings.

Number of Shares
9,113
Previous 10,329 11.77%
Holding current value
$821,901
Previous $708,000 7.77%
% of portfolio
0.08%
Previous 0.08%

Shares

42 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$66.59 - $83.99 $80,973 - $102,131
-1,216 Reduced 11.77%
9,113 $763,000
Q2 2024

Aug 02, 2024
SELL
$63.15 - $72.88 $315 - $364
-5 Reduced 0.05%
10,329 $708,000
Q1 2024

Apr 19, 2024
SELL
$71.58 - $87.29 $11,524 - $14,053
-161 Reduced 1.53%
10,334 $756,000
Q4 2023

Feb 02, 2024
BUY
$73.27 - $83.09 $50,189 - $56,916
685 Added 6.98%
10,495 $850,000
Q3 2023

Oct 19, 2023
SELL
$73.94 - $80.67 $40,445 - $44,126
-547 Reduced 5.28%
9,810 $735,000
Q2 2023

Jul 21, 2023
SELL
$76.01 - $86.7 $31,924 - $36,414
-420 Reduced 3.9%
10,357 $798,000
Q1 2023

Apr 20, 2023
BUY
$77.31 - $88.08 $2,705 - $3,082
35 Added 0.33%
10,777 $894,000
Q4 2022

Feb 22, 2023
SELL
$62.32 - $89.47 $31,783 - $45,629
-510 Reduced 4.53%
10,742 $922,000
Q3 2022

Nov 14, 2022
BUY
$59.54 - $68.01 $1,548 - $1,768
26 Added 0.23%
11,252 $694,000
Q2 2022

Aug 10, 2022
BUY
$57.72 - $65.01 $58,989 - $66,440
1,022 Added 10.02%
11,226 $694,000
Q1 2022

May 16, 2022
SELL
$57.92 - $72.58 $93,077 - $116,636
-1,607 Reduced 13.61%
10,204 $606,000
Q4 2021

Jan 18, 2022
SELL
$64.88 - $73.64 $96,217 - $109,208
-1,483 Reduced 11.16%
11,811 $858,000
Q3 2021

Nov 03, 2021
BUY
$67.69 - $73.03 $451,289 - $486,891
6,667 Added 100.6%
13,294 $929,000
Q2 2021

Jul 29, 2021
SELL
$63.47 - $69.35 $5,394 - $5,894
-85 Reduced 1.27%
6,627 $456,000
Q1 2021

May 04, 2021
SELL
$60.0 - $68.46 $448,800 - $512,080
-7,480 Reduced 52.71%
6,712 $434,000
Q4 2020

Jan 14, 2021
BUY
$56.65 - $64.55 $22,376 - $25,497
395 Added 2.86%
14,192 $827,000
Q3 2020

Nov 02, 2020
BUY
$62.1 - $78.08 $16,891 - $21,237
272 Added 2.01%
13,797 $872,000
Q2 2020

Jul 31, 2020
SELL
$72.34 - $84.0 $170,433 - $197,904
-2,356 Reduced 14.84%
13,525 $1.04 Million
Q1 2020

Apr 30, 2020
BUY
$62.63 - $80.22 $746,236 - $955,821
11,915 Added 300.43%
15,881 $1.19 Million
Q4 2019

Jan 29, 2020
SELL
$61.62 - $67.78 $92,060 - $101,263
-1,494 Reduced 27.36%
3,966 $258,000
Q3 2019

Oct 31, 2019
BUY
$62.51 - $69.0 $14,752 - $16,284
236 Added 4.52%
5,460 $346,000
Q2 2019

Aug 14, 2019
SELL
$61.87 - $69.38 $9,527 - $10,684
-154 Reduced 2.86%
5,224 $353,000
Q1 2019

May 03, 2019
SELL
$62.53 - $70.05 $50,149 - $56,180
-802 Reduced 12.98%
5,378 $350,000
Q4 2018

Feb 06, 2019
SELL
$60.54 - $79.0 $276,788 - $361,188
-4,572 Reduced 42.52%
6,180 $387,000
Q3 2018

Oct 09, 2018
BUY
$71.28 - $78.92 $98,152 - $108,672
1,377 Added 14.69%
10,752 $830,000
Q2 2018

Aug 01, 2018
SELL
$64.88 - $75.68 $524,944 - $612,326
-8,091 Reduced 46.32%
9,375 $664,000
Q1 2018

May 15, 2018
SELL
$72.84 - $88.8 $739,398 - $901,408
-10,151 Reduced 36.76%
17,466 $1.77 Million
Q4 2017

May 15, 2018
SELL
$71.15 - $83.52 $44,468 - $52,200
-625 Reduced 2.21%
27,617 $1.98 Million
Q4 2017

Feb 01, 2018
BUY
$71.15 - $83.52 $744,513 - $873,953
10,464 Added 58.86%
28,242 $2.02 Million
Q3 2017

Aug 02, 2018
SELL
$72.11 - $85.47 $169,819 - $201,281
-2,355 Reduced 11.7%
17,778 $1.44 Million
Q2 2017

Aug 30, 2018
BUY
N/A
5,516 Added 37.74%
20,133 $1.43 Million
Q1 2017

Sep 05, 2018
SELL
N/A
-4,142 Reduced 22.08%
14,617 $993,000
Q4 2016

Sep 10, 2018
BUY
N/A
18,759 New
18,759 $1.34 Million
Q3 2016

Sep 25, 2018
SELL
N/A
-7,847 Closed
0 $0
Q2 2016

Oct 01, 2018
SELL
N/A
-2,252 Reduced 22.3%
7,847 $655,000
Q1 2016

Oct 12, 2018
SELL
N/A
-2,799 Reduced 21.7%
10,099 $928,000
Q4 2015

Oct 18, 2018
BUY
N/A
2,088 Added 19.32%
12,898 $1.31 Million
Q3 2015

Oct 29, 2018
SELL
N/A
-700 Reduced 6.08%
10,810 $1.06 Million
Q2 2015

Nov 06, 2018
BUY
N/A
3,768 Added 48.67%
11,510 $1.35 Million
Q1 2015

Nov 13, 2018
SELL
N/A
-262 Reduced 3.27%
7,742 $760,000
Q4 2014

Nov 19, 2018
BUY
N/A
5,443 Added 212.53%
8,004 $754,000
Q3 2014

Dec 04, 2018
BUY
N/A
2,561
2,561 $273,000

Others Institutions Holding GILD

# of Institutions
1,923
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Kovack Advisors, Inc. Portfolio

Follow Kovack Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email